Congenital Sucrase-Isomaltase Deficiency (CSID) is an autosomal recessive disorder characterised by mutations in the gene that encodes the sucrase-isomaltase enzyme complex. This complex is essential ...
Sulfite oxidase deficiency is a rare, inherited neurometabolic disorder arising from impaired detoxification of sulfite, a by-product of sulfur‐containing amino acid catabolism. The condition is most ...
The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate ...
Thus, treating vitamin D deficiency in patients with neurocognitive disorders to an endpoint of 50 ng/mL may be considered. 1 Dana S. Miles, MS, PA-C, CAQ-EM, has been working in emergency medicine as ...
The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...
Vitamin A deficiency should be considered in children with unexplained vision loss, particularly those with restrictive eating disorders such as avoidant/restrictive food intake disorder. Early ...
Amy Shapiro, MD, medical director of Indiana Hemophilia and Thrombosis Center, joined AJMC to shed light on a broadly overlooked disorder: plasminogen deficiency type-1. Plasminogen deficiency is a ...
Other than iron deficiency, fatigue and tiredness in teenage girls can be caused due to several factors, which can disrupt their daily lives, school performance, and overall well-being.
Vitamin D and Muscle Weakness: Vitamin D is very important for our bodies. Its deficiency can cause various problems. Let us explain why this happens. Diseases caused by Vitamin D deficiency What ...
Celiac disease prevalence is increasing, with higher incidence in women and children, often underdiagnosed due to nonclassical symptoms. Vitamin deficiencies in celiac disease, such as A, E, K, B9, ...
Acid lipase deficiency is a rare genetic disorder that affects the lysosomal acid lipase (LAL) enzyme. This enzyme is crucial for managing fat and cholesterol levels throughout the body. LAL helps ...
March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports of several cases of patients' hip joint slipping out of place, the drugmaker ...